ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple

Caitlin Jackson-Tarlton1, Diana Londoño2, Claudia F Lucchinetti3

  • 1Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Abstract

Insights

Plasma exchange (PLEX) effectively treats acute MS attacks, leading to better long-term outcomes. However, apparent diffusion coefficient (ADC) restriction on MRI does not predict PLEX response in these patients.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Background:

  • Multiple Sclerosis (MS) is a leading cause of CNS inflammatory demyelination.
  • Plasma exchange (PLEX) is effective for acute, corticosteroid-refractory MS attacks.
  • Predictors of favorable PLEX response in MS remain unclear.

Purpose of the Study:

  • To investigate if apparent diffusion coefficient (ADC) restriction on brain MRI predicts clinical response to PLEX in acute MS cerebral attacks.

Main Methods:

  • Retrospective chart review of MS patients undergoing PLEX at Mayo Clinic.
  • Analysis of pre-PLEX MRI for ADC restriction.
  • Evaluation of clinical response and 6-month follow-up outcomes.

Main Results:

  • 34 MS patients met inclusion criteria; 79% responded to PLEX.
  • 47% showed moderate and 32% marked improvement.
  • ADC restriction (68% of patients) did not predict PLEX response (p=0.51).
  • Other factors like sex, EDSS, time to PLEX, and concurrent spinal cord attacks also failed to predict response.
  • PLEX responders had significantly lower 6-month EDSS scores compared to non-responders (2.5 vs. 7.5, p<0.001).

Conclusions:

  • Acute MS cerebral attacks demonstrate a high response rate to PLEX, correlating with reduced long-term disability.
  • Apparent diffusion coefficient (ADC) restriction on pre-treatment MRI is not a predictor of PLEX efficacy in MS.